avapro has been researched along with Hyperlipemia in 4 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Excerpt | Relevance | Reference |
---|---|---|
" Risk factors for diabetic nephropathy are discussed, and include hyperglycemia, hypertension, angiotensin II, proteinuria, dyslipidemia, smoking, and anemia." | 4.82 | Outcome studies in diabetic nephropathy. ( Mohanram, A; Toto, RD, 2003) |
" Therefore, we investigated whether endothelial dysfunction and/or vascular NO bioavailability is reflected by decreased vessel wall P-VASP and whether improvement of endothelial dysfunction restores this P-VASP." | 1.31 | Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction. ( Bodenschatz, M; Hoffmann, N; Meinertz, T; Mollnau, H; Münzel, T; Oelze, M; Skatchkov, M; Smolenski, A; Walter, U; Warnholtz, A, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zhao, Y | 1 |
Fukao, K | 1 |
Zhao, S | 1 |
Watanabe, A | 1 |
Hamada, T | 1 |
Yamasaki, K | 1 |
Shimizu, Y | 1 |
Kubo, N | 1 |
Ukon, N | 1 |
Nakano, T | 1 |
Tamaki, N | 1 |
Kuge, Y | 1 |
Rizos, CV | 1 |
Milionis, HJ | 1 |
Kostapanos, MS | 1 |
Florentin, M | 1 |
Kostara, CE | 1 |
Elisaf, MS | 1 |
Liberopoulos, EN | 1 |
Mohanram, A | 1 |
Toto, RD | 1 |
Oelze, M | 1 |
Mollnau, H | 1 |
Hoffmann, N | 1 |
Warnholtz, A | 1 |
Bodenschatz, M | 1 |
Smolenski, A | 1 |
Walter, U | 1 |
Skatchkov, M | 1 |
Meinertz, T | 1 |
Münzel, T | 1 |
1 review available for avapro and Hyperlipemia
Article | Year |
---|---|
Outcome studies in diabetic nephropathy.
Topics: Albuminuria; Anemia; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme | 2003 |
1 trial available for avapro and Hyperlipemia
Article | Year |
---|---|
Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Glucose; C-React | 2010 |
2 other studies available for avapro and Hyperlipemia
Article | Year |
---|---|
Irbesartan attenuates atherosclerosis in Watanabe heritable hyperlipidemic rabbits: noninvasive imaging of inflammation by 18F-fluorodeoxyglucose positron emission tomography.
Topics: Animals; Antihypertensive Agents; Atherosclerosis; Autoradiography; Biphenyl Compounds; Body Weight; | 2015 |
Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta; Biphenyl Compounds; Cell | 2000 |